DOD Biotech Public Company Limited at the Board of Directors' Meeting held on November 29, 2022 passed the resignation of Mr. Thanin Srisethi as Chief Executive Officer with effect from 30 November 2022 onward and Approved the appointment of Mr. Torlarp Chaiyachow as the Director, Acting Chief Executive Officer in place of Mr. Thanin Srisethi with effect from 1 December 2022 onwards.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 THB | -0.80% | -8.15% | -32.97% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.97% | 30.62M | |
+17.10% | 8.43B | |
+14.30% | 6.82B | |
-3.69% | 3.77B | |
-7.34% | 3.74B | |
+1.78% | 1.44B | |
-28.77% | 1.06B | |
+18.84% | 1.04B | |
-11.81% | 890M | |
-18.34% | 812M |
- Stock Market
- Equities
- DOD Stock
- News DOD Biotech
- DOD Biotech Public Company Limited Announces Executive Changes